Regulation of the sequential processing of Semliki Forest virus replicase polyprotein. 2003

Lidia Vasiljeva, and Andres Merits, and Andrey Golubtsov, and Valeria Sizemskaja, and Leevi Kääriäinen, and Tero Ahola
Program in Cellular Biotechnology, Institute of Biotechnology, Viikki Biocenter, University of Helsinki, P. O. Box 56, 00014 Helsinki, Finland.

The replication of most positive-strand RNA viruses and retroviruses is regulated by proteolytic processing. Alphavirus replicase proteins are synthesized as a polyprotein, called P1234, which is cleaved into nsP1, nsP2, nsP3, and nsP4 by the carboxyl-terminal protease domain of nsP2. The cleavage intermediate P123+nsP4 synthesizes minus-strand copies of the viral RNA genome, whereas the completely processed complex is required for plus-strand synthesis. To understand the mechanisms responsible for this sequential proteolysis, we analyzed in vitro translated Semliki Forest virus polyproteins containing noncleavable processing sites or various deletions. Processing of each of the three sites in vitro required a different type of activity. Site 3/4 was cleaved in trans by nsP2, its carboxyl-terminal fragment Pro39, and by all polyprotein proteases. Site 1/2 was cleaved in cis with a half-life of about 20-30 min. Site 2/3 was cleaved rapidly in trans but only after release of nsP1 from the polyprotein exposing an "activator" sequence present in the amino terminus of nsP2. Deletion of amino-terminal amino acids of nsP2 or addition of extra amino acid residues to its amino terminus specifically inhibited the protease activity that processes the 2/3 site. This sequence of delayed processing of P1234 would explain the accumulation of P123 plus nsP4, the early short-lived minus-strand replicase. The polyprotein stage would allow correct assembly and membrane association of the RNA-polymerase complex. Late in infection free nsP2 would cleave at site 2/3 yielding P12 and P34, the products of which, nsP1-4, are distributed to the plasma membrane, nucleus, cytoplasmic aggregates, and proteasomes, respectively.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010449 Peptide Mapping Analysis of PEPTIDES that are generated from the digestion or fragmentation of a protein or mixture of PROTEINS, by ELECTROPHORESIS; CHROMATOGRAPHY; or MASS SPECTROMETRY. The resulting peptide fingerprints are analyzed for a variety of purposes including the identification of the proteins in a sample, GENETIC POLYMORPHISMS, patterns of gene expression, and patterns diagnostic for diseases. Fingerprints, Peptide,Peptide Fingerprinting,Protein Fingerprinting,Fingerprints, Protein,Fingerprint, Peptide,Fingerprint, Protein,Fingerprinting, Peptide,Fingerprinting, Protein,Mapping, Peptide,Peptide Fingerprint,Peptide Fingerprints,Protein Fingerprint,Protein Fingerprints
D003546 Cysteine Endopeptidases ENDOPEPTIDASES which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by CYSTEINE PROTEINASE INHIBITORS such as CYSTATINS and SULFHYDRYL REAGENTS.
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D012324 RNA-Dependent RNA Polymerase An enzyme that catalyses RNA-template-directed extension of the 3'- end of an RNA strand by one nucleotide at a time, and can initiate a chain de novo. (Enzyme Nomenclature, 1992, p293) Nucleoside-Triphosphate:RNA Nucleotidyltransferase (RNA-directed),RNA Replicase,RNA-Dependent RNA Replicase,RNA-Directed RNA Polymerase,RNA Dependent RNA Polymerase,RNA Dependent RNA Replicase,RNA Directed RNA Polymerase,RNA Polymerase, RNA-Dependent,RNA Polymerase, RNA-Directed,RNA Replicase, RNA-Dependent,Replicase, RNA,Replicase, RNA-Dependent RNA
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D012672 Semliki forest virus A species of ALPHAVIRUS isolated in central, eastern, and southern Africa.
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions
D015967 Gene Expression Regulation, Viral Any of the processes by which cytoplasmic factors influence the differential control of gene action in viruses. Regulation of Gene Expression, Viral,Viral Gene Expression Regulation,Regulation, Gene Expression, Viral

Related Publications

Lidia Vasiljeva, and Andres Merits, and Andrey Golubtsov, and Valeria Sizemskaja, and Leevi Kääriäinen, and Tero Ahola
October 2017, Viruses,
Lidia Vasiljeva, and Andres Merits, and Andrey Golubtsov, and Valeria Sizemskaja, and Leevi Kääriäinen, and Tero Ahola
July 1991, The Journal of general virology,
Lidia Vasiljeva, and Andres Merits, and Andrey Golubtsov, and Valeria Sizemskaja, and Leevi Kääriäinen, and Tero Ahola
May 1987, Journal of virology,
Lidia Vasiljeva, and Andres Merits, and Andrey Golubtsov, and Valeria Sizemskaja, and Leevi Kääriäinen, and Tero Ahola
January 1980, European journal of biochemistry,
Lidia Vasiljeva, and Andres Merits, and Andrey Golubtsov, and Valeria Sizemskaja, and Leevi Kääriäinen, and Tero Ahola
April 1999, FEBS letters,
Lidia Vasiljeva, and Andres Merits, and Andrey Golubtsov, and Valeria Sizemskaja, and Leevi Kääriäinen, and Tero Ahola
May 2000, Journal of virology,
Lidia Vasiljeva, and Andres Merits, and Andrey Golubtsov, and Valeria Sizemskaja, and Leevi Kääriäinen, and Tero Ahola
February 1997, The Journal of general virology,
Lidia Vasiljeva, and Andres Merits, and Andrey Golubtsov, and Valeria Sizemskaja, and Leevi Kääriäinen, and Tero Ahola
February 2001, The Journal of biological chemistry,
Lidia Vasiljeva, and Andres Merits, and Andrey Golubtsov, and Valeria Sizemskaja, and Leevi Kääriäinen, and Tero Ahola
April 1981, FEBS letters,
Lidia Vasiljeva, and Andres Merits, and Andrey Golubtsov, and Valeria Sizemskaja, and Leevi Kääriäinen, and Tero Ahola
January 1986, Gene,
Copied contents to your clipboard!